Triptans and migraine.
Bateman
D N
DN
Scottish Poisons Information Bureau, Royal Infirmary of Edinburgh, Scotland.
D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012701:Serotonin / Q000031:analogs & derivatives*; D017366:Serotonin Receptor Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D013329:Structure-Activity Relationship; D018170:Sumatriptan / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome; D014662:Vasoconstrictor Agents / Q000009:adverse effects / Q000627:therapeutic use*
D017366:Serotonin Receptor Agonists; D014662:Vasoconstrictor Agents; D012701:Serotonin; D018170:Sumatriptan